Protalix Biotherapeutics News

Protalix BioTherapeutics Inc (PLX) Q1 2024 Earnings Call Transcript Highlights: Navigating ...

Yahoo FinanceMay 13 03:05 ET

Protalix BioTherapeutics, Inc. (AMEX:PLX) Q1 2024 Earnings Call Transcript

Yahoo FinanceMay 11 10:27 ET

Earnings Call Summary | Protalix Biotherapeutics(PLX.US) Q1 2024 Earnings Conference

The following is a summary of the Protalix BioTherapeutics, Inc. (PLX) Q1 2024 Earnings Call Transcript:Financial Performance:Protalix BioTherapeutics reported decreased revenues from goods sales to $

moomoo AIMay 10 14:30 ET · Conference Call

Protalix BioTherapeutics, Inc. (PLX) Q1 2024 Earnings Call Transcript

Protalix BioTherapeutics, Inc. (PLX) Q1 2024 Earnings Call Transcript

Earnings Call TranscriptsMay 10 11:13 ET

Novavax, Macrogenics, Biofrontera Among Healthcare Movers

Seeking AlphaMay 10 10:00 ET

NOTV, BFRI and CPOP Among Pre-market Losers

Seeking AlphaMay 10 08:30 ET

12 Health Care Stocks Moving In Friday's Pre-Market Session

GainersAethlon Medical (NASDAQ:AEMD) stock moved upwards by 129.0% to $2.7 during Friday's pre-market session. The company's market cap stands at $7.1 million. Novavax (NASDAQ:NVAX) shares rose 119.23

BenzingaMay 10 08:07 ET

Express News | Protalix BioTherapeutics Shares Are Trading Lower After the Company Reported Worse-than-expected Q1 GAAP EPS Results and Issued a Year-over-year Decrease in Q1 Sales Results

BenzingaMay 10 07:34 ET

Protalix Biotherapeutics | 10-Q: Quarterly report

Futu NewsMay 10 07:24 ET · Announcements

Express News | Protalix BioTherapeutics' Cash, Cash Equivalents And Short-term Bank Deposits Were Approximately $48.5M At March 31, 2024

BenzingaMay 10 06:54 ET

Express News | Protalix BioTherapeutics Q1 2024 GAAP EPS $(0.06) Misses $(0.02) Estimate, Sales $3.748M Down From $9.588M YoY

BenzingaMay 10 06:53 ET

Earnings Flash (PLX) PROTALIX BIOTHERAPEUTICS Reports Q1 Revenue $3.7M, Vs. Street Est of $9.2M

06:53 AM EDT, 05/10/2024 (MT Newswires) -- Earnings Flash (PLX) PROTALIX BIOTHERAPEUTICS Reports Q1 Revenue $3.7M, vs. Street Est of $9.2M

MT NewswiresMay 10 06:53 ET

Protalix BioTherapeutics 1Q Rev $3.75M >PBDA.FF

Protalix BioTherapeutics 1Q Rev $3.75M >PBDA.FF

Dow JonesMay 10 06:50 ET

Protalix BioTherapeutics 1Q Loss/Shr 6c >PBDA.FF

Protalix BioTherapeutics 1Q Loss/Shr 6c >PBDA.FF

Dow JonesMay 10 06:50 ET

Press Release: Protalix BioTherapeutics Reports First Quarter 2024 Financial and Business Results

Protalix BioTherapeutics Reports First Quarter 2024 Financial and Business Results PR Newswire CARMIEL, Israel, May 10, 2024 Company to host conference call and webcast today at 8:30 a.m. EDT CARM

Dow JonesMay 10 06:50 ET

Protalix BioTherapeutics to Announce First Quarter 2024 Financial and Business Results on May 10, 2024

Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on the development, production and commercialization of...

PR NewswireMay 3 06:50 ET

NYSE American New 52-Week Highs And Lows

New Highs 0 COMPANY SYMBOL HIGH VOLUME ------- ------ ---- ------ New Lows 11 COMPANY SYMBOL LOW

Dow JonesApr 16 10:20 ET

Protalix BioTherapeutics, Inc. (AMEX:PLX) Q4 2023 Earnings Call Transcript

Yahoo FinanceMar 15 13:17 ET

Earnings Call: Protalix BioTherapeutics Reports Fiscal Year 2023 Results

InvestingMar 14 20:00 ET

Earnings Call Summary | Protalix Biotherapeutics(PLX.US) Q4 2023 Earnings Conference

The following is a summary of the Protalix BioTherapeutics, Inc. (PLX) Q4 2023 Earnings Call Transcript:Financial Performance:Protalix reported Q4 revenues of $40.4 million, a significant increase of

moomoo AIMar 14 13:35 ET · Conference Call